Dr Reddys (Germany) Investor Sentiment

RDDA Stock  EUR 13.40  0.10  0.74%   
Roughly 62% of Dr Reddys' investor base is looking to short. The analysis of current outlook of investing in Dr Reddys Laboratories suggests that many traders are alarmed regarding Dr Reddys' prospects. The current market sentiment, together with Dr Reddys' historical and current headlines, can help investors time the market. In addition, many technical investors use Dr Reddys Laboratories stock news signals to limit their universe of possible portfolio assets.
Dr Reddys stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of RDDA daily returns and investor perception about the current price of Dr Reddys Laboratories as well as its diversification or hedging effects on your existing portfolios.
  
over a week ago at news.google.com         
Dr. Reddys Gains Strong Rating Amid Robust Growth - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Dr. Reddys shares trade ex-split today. Stock up 2 percent - The Economic Times
Google News at Macroaxis
over a month ago at news.google.com         
Announcements Updates Announcement under Regulation 30 -Updates on Acquisition - The Economic Times
Google News at Macroaxis
over a month ago at news.google.com         
Stocks to Watch IDFC First Bank, PNB, Dr Reddys, REC, RIL, Welspun Enterprises, Biocon, and more Sto...
Google News at Macroaxis
over two months ago at news.google.com         
Coal India and 2 more Axis Direct recommends buying these stocks for 5-15 days Check targets, stop l...
Google News at Macroaxis
over two months ago at news.google.com         
Announcements Updates Compliances-Reg. - Details of Loss of Certificate Duplicate Certificate - The ...
Google News at Macroaxis
over two months ago at news.google.com         
Dr. Reddys Laboratories Stocks Live Updates Dr. Reddys Laboratories Sees Minor Decline in Stock Pric...
Google News at Macroaxis
over two months ago at news.google.com         
Chinas NMPA suspends import, sale of Dr. Reddys ADHD drug shares slump 2.26 percent - The Hindu
Google News at Macroaxis
over two months ago at news.google.com         
Dr Reddys shares sink after Chinese authority suspends import, sale, use of its Atomoxetine Hydrochl...
Google News at Macroaxis
over three months ago at news.google.com         
Dr. Reddys shares hit record high Pharma stock up 5 percent in 3 sessions - Fortune India
Google News at Macroaxis
over three months ago at news.google.com         
If EPS Growth Is Important To You, Dr. Reddys Laboratories Presents An Opportunity - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Dr Reddys Laboratories, TCS top stocks to buy post June quarter results Siddhartha Khemka - The Econ...
Google News at Macroaxis
over three months ago at news.google.com         
Dr Reddys Labs shares drop after US FDA gives VIA tag to Vizag facilities - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Dr. Reddys Laboratories Hits New 52-Week High at 82.89 - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Announcements Updates Shareholder Meeting Postal Ballot-Scrutinizers Report - The Economic Times
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Dr Reddys that are available to investors today. That information is available publicly through RDDA media outlets and privately through word of mouth or via RDDA internal channels. However, regardless of the origin, that massive amount of RDDA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Dr Reddys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Dr Reddys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Dr Reddys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Dr Reddys alpha.

Dr Reddys Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for RDDA Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities